Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 1 Pain 1 Lymphoma, Non-Hodgkin 1 Hysterectomies for Low- or Intermediate-risk Endometrial Carcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Agnosia 1

Interventions

Bupivacaine 11 Ketamine 9 Ropivacaine 8 Morphine 8 Acetaminophen 8 Fentanyl 7 Dexmedetomidine 7 Lidocaine 6 Anesthesia, General 6 Analgesics, Opioid 6 Saline Solution 5 Anesthesia, Local 5 Acupuncture Therapy 5 parecoxib 4 Tramadol 4 Sodium Chloride 4 Pregabalin 4 Ethanol 4 Analgesia, Epidural 4 Transcutaneous Electric Nerve Stimulation 3 Radiofrequency Ablation 3 Propofol 3 Oxycodone 3 Ketorolac 3 Control Groups 3 Anesthetics, Local 3 trimebutine 3-thiocarbamoylbenzenesulfonate 2 Therapeutics 2 Surveys and Questionnaires 2 Magnesium Sulfate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Agnosia × Analgesics × Clear all

NCT02718404 2022-06-30

HIFU-Bone

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Phase NA Terminated

Agnosia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡